1-20 of 48
Ruth Jessen Hickman, MD
Close
Sort by
News

Bivalent Lentiviral-Based Gene Therapy Might Decrease Costs in Sickle Cell Disease

Ruth Jessen Hickman, MD
Published: 2024
Abstract
September 2024
View News titled, Bivalent Lentiviral-Based Gene Therapy Might Decrease Costs in Sickle Cell Disease
News

Full Results of Exa-Cel Study Show Continued Safety, Efficacy in Sickle Cell Disease

Ruth Jessen Hickman, MD
Published: 2024
Abstract
August 2024
View News titled, Full Results of Exa-Cel Study Show Continued Safety, Efficacy in Sickle Cell Disease
News

Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies
News

Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi
News

Patients With Low-Grade NHL Experience High Rates of Mental Health Conditions

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Patients With Low-Grade NHL Experience High Rates of Mental Health Conditions
News

Results Encouraging for Glofitamab in CNS Involvement in B-Cell Lymphoma

Ruth Jessen Hickman, MD
Published: 2024
Abstract
June 2024
View News titled, Results Encouraging for Glofitamab in CNS Involvement in B-Cell Lymphoma
News

Study Explores Endothelial Mechanisms of Hydroxyurea’s Stroke Prevention in SCA

Ruth Jessen Hickman, MD
Published: 2024
Abstract
June 2024
View News titled, Study Explores Endothelial Mechanisms of Hydroxyurea’s Stroke Prevention in SCA
News

Cost-Benefit Analysis Favorable but Challenging for Gene Therapy for SCD

Ruth Jessen Hickman, MD
Published: 2024
Abstract
May 2024
View News titled, Cost-Benefit Analysis Favorable but Challenging for Gene Therapy for SCD
News

Mobile Apps Tackle High Rates of Depression, Chronic Pain in Sickle Cell Disease

Ruth Jessen Hickman, MD
Published: 2024
Abstract
April 2024
View News titled, Mobile Apps Tackle High Rates of Depression, Chronic Pain in Sickle Cell Disease
News

CD20 Loss a Cause of Mosunetuzumab Resistance in Non-Hodgkin Lymphoma

Ruth Jessen Hickman, MD
Published: 2024
Abstract
March 2024
View News titled, CD20 Loss a Cause of Mosunetuzumab Resistance in Non-Hodgkin Lymphoma
News

Study Identifies Drugs With Greatest Association With Drug-Induced Hemolytic Anemia

Ruth Jessen Hickman, MD
Published: 2024
Abstract
February 2024
View News titled, Study Identifies Drugs With Greatest Association With Drug-Induced Hemolytic Anemia
News

Social Determinants of Health Influence Treatment Delivery in Acute Leukemia

Ruth Jessen Hickman, MD
Published: 2023
Abstract
January 2024
View News titled, Social Determinants of Health Influence Treatment Delivery in Acute Leukemia
News

Venetoclax as Additional Therapy in Mantle Cell Lymphoma Yields High Response Rates

Ruth Jessen Hickman, MD
Published: 2023
Abstract
January 2024
View News titled, Venetoclax as Additional Therapy in Mantle Cell Lymphoma Yields High Response Rates
News

Better Scoring Systems Needed for Bleeding Risk Assessment in Patients With Cancer

Ruth Jessen Hickman, MD
Published: 2023
Abstract
January 2024
View News titled, Better Scoring Systems Needed for Bleeding Risk Assessment in Patients With Cancer
News

Axatilimab, First-in-Class Treatment for Chronic GVHD, Shows Strong Phase II Results

Ruth Jessen Hickman, MD
Published: 2023
Abstract
January 2024
View News titled, Axatilimab, First-in-Class Treatment for Chronic GVHD, Shows Strong Phase II Results
News

Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia

Ruth Jessen Hickman, MD
Published: 2023
Abstract
December 2023
View News titled, Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia
News

Real-World Studies Show Poorer Outcomes for Tafasitamab, Lenalidomide in R/R LBCL

Ruth Jessen Hickman, MD
Published: 2023
Abstract
December 2023
View News titled, Real-World Studies Show Poorer Outcomes for Tafasitamab, Lenalidomide in R/R LBCL
News

Eligibility Criteria Can Limit Patient Access

Ruth Jessen Hickman, MD
Published: 2023
Abstract
Mid-November 2023
View News titled, Eligibility Criteria Can Limit Patient Access
News

Pacritinib Is One Option for Patients with Myelofibrosis and Anemia

Ruth Jessen Hickman, MD
Published: 2023
Abstract
Mid-November 2023
View News titled, Pacritinib Is One Option for Patients with Myelofibrosis and Anemia
News

Spreading the Word About Supplemental Funding for SCD Centers

Ruth Jessen Hickman, MD
Published: 2023
Abstract
Mid-November 2023
View News titled, Spreading the Word About Supplemental Funding for SCD Centers